The News Vista is dedicated to delivering accurate, timely, and unbiased news to keep our readers informed. We cover a wide range of topics including current affairs, politics, business, technology, and more.
The Centre has issued a detailed advisory on GLP-1 receptor agonist drugs, emphasizing their use for type 2 diabetes and obesity must be strictly under medical supervision. Authorities are increasing regulatory surveillance and warning of strict action against violations in their sale or prescription.
